InMed Receives NASDAQ Delisting Notice, and Confirms it has Filed an Appeal and Obtained a Panel Hearing Date
Friday, 20 September 2024 () September 20, 2024 4:30 PM EDT | Source: InMed Pharmaceuticals Vancouver, British Columbia–(Newsfile Corp. – September 20, 2024) – InMed Pharmaceuticals Inc. (NASDAQ: INM) (“InMed” or the “Company”), a pharmaceutical company focused on developing a pipeline of proprietary small molecule drug candidates for diseases with high unmet medical needs, today announced that it has timely […]
Friday, 20 September 2024 ()
September 20, 2024 4:30 PM EDT | Source: InMed Pharmaceuticals Vancouver, British Columbia–(Newsfile Corp. – September 20, 2024) – InMed Pharmaceuticals Inc. (NASDAQ: INM) (“InMed” or the “Company”), a pharmaceutical company focused on developing a pipeline of proprietary small molecule drug candidates for diseases with high unmet medical needs, today announced that it has timely […]